Indicators of carbohydrate metabolism in a patient with dyslipidemia and impaired fasting glycemia receiving pitavastatin: a case report
Statins have diabetogenic properties. Pitavastatin is currently considered the only drug in this group that combines high lipid-correcting activity with the absence of a negative effect on carbohydrate metabolism. The article presents a case of correction of carbohydrate metabolism indicators agains...
Saved in:
Main Authors: | A. A. Nekrasov, E. S. Timoshchenko, D. V. Cherneva, I. N. Volovatova, T. A. Nekrasova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2023-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3496 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
by: V. V. Syvolap, et al.
Published: (2014-04-01) -
Endothelial protective effect of pitavastatin
by: A. S. Berns, et al.
Published: (2023-10-01) -
Pitavastatin – a new inhibitor of the HMG-CoA reductase: peculiarities of clinical pharmacology and perspectives of its usage in treatment of cardiovascular diseases.
by: G. V. Dzyak, et al.
Published: (2013-12-01) -
Prevalence of carbohydrate metabolism disorders and association with cardiovascular diseases in a large Siberian region
by: V. V. Shabalin, et al.
Published: (2022-06-01) -
Outpatient follow-up of patients with myocardial infarction and early carbohydrate metabolism disorders
by: E. P. Kalaidzhyan, et al.
Published: (2025-04-01)